510(k) K152864
K152864 is an FDA 510(k) premarket notification submitted by Merge Healthcare Incorporated for the device "Merge Hemo". The FDA issued a decision of Substantially Equivalent on April 7, 2016. The device falls under product code DQK (Computer, Diagnostic, Programmable), a Class II device regulated under 21 CFR 870.1425. Merge Healthcare Incorporated has at least 7 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 7, 2016
- Date Received
- September 30, 2015
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Computer, Diagnostic, Programmable
- Device Class
- Class II
- Regulation Number
- 870.1425
- Review Panel
- CV
- Submission Type